BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33259599)

  • 41. Severe Congenital Neutropenia Type 4: A Rare Disease Harboring a G6pc3 Gene Pathogenic Variant Particular to the Mexican Population.
    López-Rodríguez L; Svyryd Y; Benítez-Alonso EO; Rivero-García P; Luna-Muñoz L; Mutchinick OM
    Rev Invest Clin; 2022; 74(6):328-339. PubMed ID: 36546889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms.
    Donini M; Fontana S; Savoldi G; Vermi W; Tassone L; Gentili F; Zenaro E; Ferrari D; Notarangelo LD; Porta F; Facchetti F; Notarangelo LD; Dusi S; Badolato R
    Blood; 2007 Jun; 109(11):4716-23. PubMed ID: 17311988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional characteristics of circulating granulocytes in severe congenital neutropenia caused by ELANE mutations.
    Liu Q; Sundqvist M; Li W; Holdfeldt A; Zhang L; Björkman L; Bylund J; Dahlgren C; Wang C; Zhao X; Forsman H
    BMC Pediatr; 2019 Jun; 19(1):189. PubMed ID: 31176364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta.
    Cheung YY; Kim SY; Yiu WH; Pan CJ; Jun HS; Ruef RA; Lee EJ; Westphal H; Mansfield BC; Chou JY
    J Clin Invest; 2007 Mar; 117(3):784-93. PubMed ID: 17318259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.
    Lieschke GJ; Grail D; Hodgson G; Metcalf D; Stanley E; Cheers C; Fowler KJ; Basu S; Zhan YF; Dunn AR
    Blood; 1994 Sep; 84(6):1737-46. PubMed ID: 7521686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycogen storage disease type Ib neutrophils exhibit impaired cell adhesion and migration.
    Kim GY; Lee YM; Kwon JH; Jun HS; Chou J
    Biochem Biophys Res Commun; 2017 Jan; 482(4):569-574. PubMed ID: 27864142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Homozygous c.130-131 ins A (pW44X) mutation in the HAX1 gene as the most common cause of congenital neutropenia in Turkey: Report from the Turkish Severe Congenital Neutropenia Registry.
    Yılmaz Karapınar D; Patıroğlu T; Metin A; Çalışkan Ü; Celkan T; Yılmaz B; Karakaş Z; Karapınar TH; Akıncı B; Özkınay F; Onay H; Yeşilipek MA; Akar HH; Tüysüz G; Tokgöz H; Özdemir GN; Aslan Kıykım A; Karaman S; Kılınç Y; Oymak Y; Küpesiz A; Olcay L; Keskin Yıldırım Z; Aydoğan G; Gökçe M; İleri T; Aral YZ; Bay A; Atabay B; Kaya Z; Söker M; Özdemir Karadaş N; Özbek U; Özsait Selçuk B; Özdemir HH; Uygun V; Tezcan Karasu G; Yılmaz Ş
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27923. PubMed ID: 31321910
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.
    Qiu Y; Zhang Y; Hu N; Dong F
    J Biol Chem; 2017 Feb; 292(8):3496-3505. PubMed ID: 28073911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screening of genetic variants in
    Arunachalam AK; Suresh H; Edison ES; Korula A; Aboobacker FN; George B; Shaji RV; Mathews V; Balasubramanian P
    J Clin Pathol; 2020 Jun; 73(6):322-327. PubMed ID: 31732620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Novel Mutation in G6PC3 Gene Associated Non-syndromic Severe Congenital Neutropenia.
    Khera S; Pramanik SK; Patnaik SK
    Indian Pediatr; 2020 Jun; 57(6):574-575. PubMed ID: 32562405
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical spectrum and long-term follow-up of 14 cases with G6PC3 mutations from the French Severe Congenital Neutropenia Registry.
    Desplantes C; Fremond ML; Beaupain B; Harousseau JL; Buzyn A; Pellier I; Roques G; Morville P; Paillard C; Bruneau J; Pinson L; Jeziorski E; Vannier JP; Picard C; Bellanger F; Romero N; de Pontual L; Lapillonne H; Lutz P; Chantelot CB; Donadieu J
    Orphanet J Rare Dis; 2014 Dec; 9():183. PubMed ID: 25491320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropenia.
    Smith BN; Evans C; Ali A; Ancliff PJ; Hayee B; Segal AW; Hall G; Kaya Z; Shakoori AR; Linch DC; Gale RE
    Br J Haematol; 2012 Jul; 158(1):146-9. PubMed ID: 22469094
    [No Abstract]   [Full Text] [Related]  

  • 54. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene.
    Hermans MH; Antonissen C; Ward AC; Mayen AE; Ploemacher RE; Touw IP
    J Exp Med; 1999 Feb; 189(4):683-92. PubMed ID: 9989983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adult siblings with homozygous G6PC3 mutations expand our understanding of the severe congenital neutropenia type 4 (SCN4) phenotype.
    Fernandez BA; Green JS; Bursey F; Barrett B; MacMillan A; McColl S; Fernandez S; Rahman P; Mahoney K; Pereira SL; Scherer SW; Boycott KM; Woods MO;
    BMC Med Genet; 2012 Nov; 13():111. PubMed ID: 23171239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia.
    Jeha S; Chan KW; Aprikyan AG; Hoots WK; Culbert S; Zietz H; Dale DC; Albitar M
    Blood; 2000 Nov; 96(10):3647-9. PubMed ID: 11071667
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cells.
    Hoffmann D; Kuehle J; Lenz D; Philipp F; Zychlinski D; Lachmann N; Moritz T; Steinemann D; Morgan M; Skokowa J; Klein C; Schambach A
    Gene Ther; 2020 Jun; 27(6):297-306. PubMed ID: 32051561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Severe Congenital Neutropenia Type 4 Case (G6PC3 Mutation) Presented With Large Platelets in the Peripheral Smear.
    Kaymak Cihan M; Bolat F; Onay H; Sari A; Ünver Korğali E; Aslan Ş; Cura C; İçağasioğlu D
    J Pediatr Hematol Oncol; 2016 May; 38(4):324-8. PubMed ID: 26808373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.
    Tidow N; Pilz C; Teichmann B; Müller-Brechlin A; Germeshausen M; Kasper B; Rauprich P; Sykora KW; Welte K
    Blood; 1997 Apr; 89(7):2369-75. PubMed ID: 9116280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of receptors for granulocyte colony-stimulating factor on neutrophils from patients with severe congenital neutropenia and cyclic neutropenia.
    Kyas U; Pietsch T; Welte K
    Blood; 1992 Mar; 79(5):1144-7. PubMed ID: 1371412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.